SiO2 Medical Products (SMP) has developed a new material and a method of manufacturing for primary containers that solves the industry’s major problems associated with glass and plastic primary containers and addresses the requirements for emerging parenteral drugs, in particular, protein-based drugs. Traditional approaches to improve the performance of vials and syringes have reached their limits.
Using the proprietary PECVD process, SMP’s coated primary containers are able to provide an oxygen and solute barrier, similar to that of a glass container, without any of the impurities, metals, or chemicals associated with Type 1 Borosilicate Glass. SMP’s coated containers contain no silicone oil, which allows for it to be the lowest particle system available, eliminating aggregation and the effects of immunogenicity associated with particles. Due to the stable nature of the coating, there are virtually no extractables and extremely low particles. SMP incorporates a unique ID on each container that enables individual unit serialization and tracking. An electronic record containing the manufacturing process data associated with each container is stored and made available to the drug manufacturing supply chain.
Luer Lock Syringes
Staked Needle Syringes
In order to become your preferred vendor, SMP needs to know more about you and your project to ensure that our products are compatible with yours. If you are interested in using an SMP container, please fill out our Product Questionnaire form below and send back to our technical services team at email@example.com.
© 2016 SiO₂ Medical Products, Inc.